Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3829_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
14 Мб
Скачать
☆
34. Burnand KG , Clemenson G , Gaunt J , Browse NL .  e e ect of sus-
https://t.me/med1917
tained venous hypertension in the skin and capillaries of the canine hind limb , Br J Surg . 1981 . 69 : 41–44 .
35. Browse NL , Burnand KG .  e cause of venous ulceration , Lancet . 1982 . 2 : 243–245 .
36. Smith PDC ,  omas P , Scurr JH , Dormandy JA . Causes of venous ulceration:Anew hypothesis , Br Med J . 1988 . 296 : 1726–1727 .
37.  omas P , Nash GB , Dormandy JA . White cell accumulation in dependent legs of patients with venous hypertension: A pos­sible mechanism for trophic changes in the skin , Br Med J . 1988 . 296 : 1693–1695 .
38. Scott HJ , Smith PDC , Scurr JH . Histological study of white blood cells and their association with lipodermatosclerosis and venous ulceration , Br J Surg . 1991 . 78 : 210–211 .
39. Wilkinson LS , Bunker C , Edward JCW , Scurr JH , Smith PDC . Leukocytes:  eir role in the etiopathogenesis of skin damage in venous disease , J Vasc Surg . 1993 . 17 : 669–675 .
40. Pappas PJ , DeFouw DO , Venezio LM , etal. Morphometric assess­ment of the dermal microcirculation in patients with chronic venous insu ciency , J Vasc Surg . 1997 . 26 : 784–795 .
41. Pappas PJ , Fallek SR , Garcia A , etal. Role of leukocyte activation in patients with venous stasis ulcers , J Surg Res . 1995 . 59 : 553–559 .
42. Pappas PJ , Teehan EP , Fallek SR , etal. Diminished mononuclear cell function is associated with chronic venous insu ciency , J Vasc Surg . 1995 . 22 : 580–586 .
43. Leu AJ , Leu HJ , Franzeck UK , Bollinger A . Microvascular changes in chronic venous insu ciency: Areview , Cardiovasc Surg . 1995 . 3 : 237–245 .
44. Leu HJ . Morphology of chronic venous insu ciency-light and elec­tron microscopic examinations , Vasa . 1991 . 20 : 330–342 .
45. Wenner A , Leu HJ , Spycher M , Brunner U . Ultrastructural changes of capillaries in chronic venous insu ciency , Expl Cell Biol . 1980 . 48 : 1–14 .
46. Scelsi R , Scelsi L , Cortinovis R , Poggi P . Morphological changes of dermal blood and lymphatic vessels in chronic venous insu ciency of the leg , Int Angiol. 1994 . 13 : 308–311 .
47. Saarien J , Lalkkinen N , Welgus HG , Kovannen PT . Activation of human interstitial procollagenase through direct cleavage of the Leu83- r84 bond by mast cell chymase , J Biol Chem 269 : 18134–18140 .
48. Lees M , Taylor DJ , Woolley DE . Mast cell proteinases activate pre­cursor forms of collagenase and stromelysin, but not of gelatinases Aand B , Eur J Biochem. 1994 . 223 : 171–177 .
49. Kruger-Drasagakes S , Grutzkau A , Baghramian R , Henz BM . Interactions of immature human mast cells with extracellular matrix:Expression of speci c adhesion receptors and their role in cell binding to matrix proteins, J Invest Dermatol . 1996 . 106 : 538–543 .
50. Taipale J , Keski-Oja J . Growth factors in the extracellular matrix , FASEB J. 1997 . 11 : 51–59 .
51. Roberts AB , Flanders KC , Kondaiah P , etal. Transforming growth factor β: Biochemistry and roles in embryogenesis, tissue repair, and remodeling, and carcinogenesis , Recent Prog Horm Res . 1988 . 44 : 157–197 .
52. Herrick S , Sloan P , McGurk M , Freak L , McCollum CN , Ferguson WJ . Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers , Am J Pathol . 1992 . 141 : 1085–1095 .
53. Bishop JE . Regulation of cardiovascular collagen deposition by mechanical forces , Molec Med Today . 1998 . 4 : 69–75 .
54. Higley HR , Kassander GA , Gerhardt CO , Falanga V . Extravasation of macromolecules and possible trapping of transforming growth factor-β1 in venous ulceration , Br J Surg . 1995 . 132 : 79–85 .
55. Peschen M , Lahaye T , Gennig B , Weyl A , Simon JC , Wolfgang V . Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1, and VLA-4 in the skin is modulated in progressing stages of chronic venous insu ciency , Acta Derm Venereol . 1999 . 79 : 27–32 .
56. Pappas PJ , You R , Rameshwar P , et al. Dermal tissue  brosis in patients with chronic venous insu ciency is associated with
. 1994 .
increased transforming growth factor-β1 gene expression and pro­tein production, J Vasc Surg . 1999 . 30 : 1129–1145 .
57. Taipale J , Saharinen J , Hedman K , Keski-oja J . Latent transform­ing growth factor-β1 and its binding protein are components of extracellular matrix micro brils , J Histochem Cytochem . 1996 . 44 : 875–889 .
58. Border WA , Noble NA . Transforming growth factor β in tissue  brosis , N Engl J Med . 1994 . 331 : 1286–1292 .
59. O’Kane S , Ferguson WJ . Transforming growth factor βs and wound healing , Int J Biochem Cell Biol . 1997 . 29 : 63–78 .
60. Grande JP . Role of transforming growth factor-β in tissue injury and repair , PSEBM . 1997 . 214 : 27c40 .
61. Shields DA , Sarin AS , Scurr JH , Smith PDC . Plasma elastase in venous disease , Br J Surg . 1994 . 81
62. Peschen M , Grenz H , Brand-Saberi B , etal. Increased expression of platelet-derived growth factor receptor alpha and beta and vascular endothelial growth factor in the skin of patients with chronic venous insu ciency,
63. Hasan A , Murata H , Falabella A , et al. Dermal  broblasts from venous ulcers are unresponsive to the action of transforming growth factor-β1 , J Derm Sci . 1997 . 16 : 59–66 .
64. Kim B , Kim HT , Park SH , etal. Fibroblasts from chronic wounds show altered TGF-β signaling and decreased TGF-β type II receptor expression , J Cell Physiol 2003 . 195 : 331–336 .
65. Herrick SE , Ireland GW , Simon D , McCollum CN , Ferguson MW . Venous ulcer  broblasts compared with normal  broblasts show di erences in collagen but not in  bronectin production under both normal and hypoxic conditions , J Invest Dermatol . 1996 . 106 : 187–193 .
66. Stanley AC , Park H , Phillips TJ , Russakovsky V , Menzoian JO . Reduced growth of dermal  broblasts from chronic venous ulcers can be stimulated with growth factors , J Vasc Surg . 1997 . 26 : 994–1001 .
67. Mendez MV , Stanley A , Park H , Shon K , Phillips TJ , Menzoian JO . Fibroblasts cultured from venous ulcers display cellular characteris­tics of senescence, J Vasc Surg . 1998 . 28 : 876–883 .
68. Lal BK , Saito S , Pappas PJ , etal. Altered proliferative responses of dermal  broblasts to TGF-β1 may contribute to chronic venous sta­sis ulcers , J Vasc Surg . 2003 . 37 : 1285–1293 .
69. Mendez MV , Stanley A , Phillips TJ , Murphy M , Menzoian JO , Park H . Fibroblasts cultured from distal lower extremities in patients with venous re ux display cellular characteristics of senescence , J Vasc Surg . 1998 . 28 : 1040–1050 .
70. Weckroth M , Vaheri A , Lauharanta J , Sorsa T , Konttinen YT . Matrix metalloproteinases, gelatinase, and collagenase, in chronic leg ulcers , J Invest Dermatol . 1996 . 106 : 1119–1124 .
71. Wysocki AB , Staiano-Coico L , Grinell F . Wound  uid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9 , J Invest Dermatol . 1993 . 101 : 64–68 .
72. Bullen EC , Longaker MT , Updike DL , et al. Tissue inhibi­tor of metalloproteinases-1 is decreased and activated gelatin­ases are increased in chronic wounds , J Invest Dermatol . 1995 . 104 : 236–240 .
73. Herouy Y , May AE , Pornschlegel G , etal. Lipodermatosclerosis is characterized by elevated expression and activation of matrix metal­loproteinases: Implications for venous ulcer formation , J Invest Dermatol . 1998 . 111 : 822–827 .
74. Herouy Y , Trefzer D , Zimpfer U , Schopf E , Vanscheidt W , Norgauer J . Matrix metalloproteinases and venous leg ulceration , Eur J Dermatol . 2000 . 9 : 173–180 .
75. Norgauer J , Hildenbrand T , Idzko M , et al. Elevated expression of extracellular matrix metalloproteinase inducer (CD 147) and membrane-type matrix metalloproteinases in venous leg ulcers , Br J Dermatol . 2002 . 147 : 1180–1186 .
76. Saito S , Trovato MJ , You R , etal. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insu ciency , J Vasc Surg . 2001 . 34 ( 5 ): 930–938 .
77. Herouy Y , Trefzer D , Hellstern MO , etal. Plasminogen activation in venous leg ulcers , Br J Dermatol . 2000 . 143 : 930–936 .
Arch Dermatol Res . 1998 . 290 : 291–297 .
: 1496–1499 .
78 • BASIC CONSIDERATIONS
9 .
https://t.me/med1917
MECHANISM AND EFFECTS OF
COMPRESSION THERAPY
Hugo Partsch
ompression therapy is a very e ective treatment modality whose mechanisms are not yet fully
C
face pressure and sti ness.
sion device on a speci c skin area. Sti ness is de ned by the increase of the interface pressure induced by the increase of the circumference of a limb segment when muscles are contracting.
understood.
 e clinical e ects depend mainly on two factors, inter-
Interface pressure is the pressure exerted by a compres-
1
I N T E R F A C E P R E S S U R E
However, comparisons may also be problematic because the given ranges are measured by di erent methods.  ese facts underline the necessity of in vivo pressure measurements on the individual leg, at least in future clinical studies.
 e unit for pressure is 1 Pascal (Pa), which is 1 Newton (N) per square meter. In the medical  eld, for example, measuring blood pressure, the usual unit for pressure is the weight of one cubic millimeter of mercury.
 e pressure values in Table9.1 refer to the ankle region, called the level B.Proximal measuring points on the legare:
•
B1, the point at which the Achilles tendon changes into
the calfmuscle
1
COMPRESSION HOSIERY
 e pressure ranges given for compression hosiery are mea­sured in the laboratories of the producers by determining the force that is necessary to stretch the ankle part of the stocking in transverse direction.  e pressure values are cal­culated from the force-extension diagram of the elastic fab­ric, the so-called hysteresis curve, projected to a leg model with de ned circular cross sections using Laplace’s law.  is formula describes the relationship between the inter­face pressure (P), which is directly proportional to the ten­sion (T)of the bandage and inversely proportional to the radius (R)of the curvature to which it is applied (P=T/R).  e proportion of stretch and force, which corresponds to the steepness of the so-called slope in the hysteresis curve, re ects the elasticity of the material of the stocking.
Several industrial measuring systems for obtaining hys­teresis curves are used, such as the Hosy method, the Hatra tester, the Instron method, the French ITF method, and
2
others.
ready-to-wear and custom stockings used in several coun­tries.  e range of compression pressures and the description of these classes vary among di erent countries.  erefore, it is recommended to use the pressure range in mmHg rather than compression classes for a better universal understanding.
Table9.1 gives a comparison of compression classes for
•
C, corresponding to the calf at its maximumgirth
•
D, just below the tibial tuberosity
•
E, over the patella
•
F, between KandE
•
G, 5cm below K in the upright position
•
H, at the greatest lateral trochanteric projections of the
buttock
•
K, at the center point of thecrotch
As the circumference of the leg progressively increases, a compression gradient is produced, which is de ned by the European prestandard as follows: for level B1, 70–100%; for C and D, 50–80%; and for F or G, 20–40% for com­pression classIII and IV, 20–60% for the classes A–I, and 20–50% for classII.
C O M P R E S S I O N B A N D A G E S
 e interface pressure of compression bandages depends on the experience and the skill of the bandager and only rarely is declared. For future trials it will be essential to measure the interface pressure as a parameter characterizing the “dosage” and hence the e cacy of the bandage.
79
Table9.1 COMPRESSION CLASSES OF COMPRESSION STOCKINGS USED IN SEVERAL COUNTRIES VALUES ARE
https://t.me/med1917
MMHG, 1MMHG=1333HPA
COMPRESSION CLASS EU CEN64 USA UK BS 661265 FRANCE GERMANY66
A I II III IV
 e values indicate the compression exerted by the hosiery at a hypothetical cylindricalankle
10–14 (light) 15–21 (mild) 23–32 (moderate) 34–46 (strong) >49 (very strong)
15–20 (moderate) 20–30 (rm) 30–40 (extra rm) 40+
14–17 (light) 18–24 (medium) 25–35 (strong)
10–15 15–20 20–36 >36
18–21 (light) 23–32 (medium) 34–46 (strong) >49 (very strong)
Several devices for measuring the interface pressure on
2,3
the individual leg have been described.
 e pressure mea­sured under static (resting) conditions is termed resting pressure; that measured on the moving patient is known as working pressure.
When pressure data are reported it is essential to indi-
cate the type and size of the transducer and the exact local-
4
ization on the extremity.
 e ankle region, which is a reference point for stocking manufacturers (B-segment), is not a suitable location for reliable in vivo measurement because of the radius changes varying widely due to the bony prominences and tendons prevailing in this segment.  is is the reason why some reports of stocking pressures have given lower values from B than from the more proximal segmentB1.
S T I F F N E S S
It has been shown that compression devices exerting the same resting pressure have di erent hemodynamic e ects on venous re ux and venous pumping function depending
5
on the elastic property of the material.
 is can be char­acterized by the sti ness, which plays an important role concerning the performance of a compression device during standing and walking, and which can be measured invivo.
Sti ness is de ned by the increase of compression per centimeter increase in the circumference of the leg, expressed in hectopascals per centimeter and/or millime-
1
ters of mercury per centimeter.
Avery appropriate method
to measure a dynamic sti ness index during walking has
6
been described by a Dutch group.
However, this technique requires sophisticated instrumentation and can be per­formed only in specialized laboratories.
We have proposed a very simple method that is able to di erentiate inelastic from elastic material by measuring the di erence between the standing pressure and the supine pressure at the B1 region, which is the area where the tendi­nous part of the medial gastrocnemius muscle changes into
7
the muscular part.
 e standing position is considered to be a snapshot of the walking cycle.  erefore pressure sen­sors also may be used that are not able to register continuous pressure changes.
Especially when several textiles are combined in a multi-
layer bandage, the sti ness of the  nal bandage will increase
2
because of the friction of the layers.
 e same is true when
two compression stockings are donned over eachother.
Compared with in vivo measurements sti ness corre-
8
sponds to the slope of the hysteresis curve in vitro.
COMPRESSION MATERIAL
Based on the principles mentioned earlier, several textiles used for compression therapy can be di erentiated (see Table9.2).
PERFORMANCE OF
COMPRESSION MATERIALS
Elastic textiles exert pressure by being stretched. During walking only small pressure peaks will occur, because the elastic material gives way with every step.  e working pres­sure is therefore not much higher than the resting pressure (see Figure 9.1). Because of the retraction of the elastic  bers there is only a small reduction of interface pressure in the sitting and lying position. Acontinuous high resting
Table9.2 COMPRESSION MATERIALS
ELASTIC, LONGSTRETCH MATERIAL INELASTIC, SHORTSTRETCH MATERIAL NONSTRETCH MATERIAL
Compression stockings Long-stretch bandages Extensibilty >100% Low sti ness Exerts pressure when applied with stretch
*Bandages consisting of several elastic components with an extensibility of the single layer >100% for example as the “four-layer bandage,” will become relatively inelastic when applied in more layers and therefore may also be ranged into this category.
Short-stretch bandages Multilayer short-stretch bandages* Extensibility <100%* Medium sti ness Pressure increases when movement causes
calf muscle to contract
80 • BASIC CONSIDERATIONS
Zinc paste bandages, Unna boot Velcro band devices (also short stretch) Extensibility 0–10% High sti ness Pressure increases when movement causes
calf muscle to contract
90
https://t.me/med1917
80 70 60 50 40
mmHg
30 20 10
0
Resting vs. Working Pressure
Elastic
Inelastic
applied with several elastic layers get similar elastic proper­ties as short-stretch bandages.
Intermittent pneumatic compression o ers adjunctive bene cial e ects, especially in patients with a restricted walking ability. In addition to the decongestive e ect, an increase of arterial  ow and a release of vasoactive and anti­coagulatory mediators from the endothelial cells have been
10,12
documented during the last few years.
Standing
Figure9.1 Interface pressure measured on the medial aspect of the leg (B1) of an elastic and an inelastic bandage. Both bandages are  rmly applied and exert a pressure of 60mmHg immediately a er application in the standing position. During walking much higher pressure peaks are obtained with inelastic than with elastic material. When the patient lies down and also a er 24 hours, elastic bandages show only a mild reduction of pressure.  e more intense pressure loss of the inelastic material is the reason why these bandages also are tolerated during nighttime, and why they should be renewed when getting tooloose.
Walking
Recumbent
After 24 h
pressure may cause unpleasant feelings during rest and is strictly contraindicated in patients with arterial occlusive disease.  erefore elastic bandages and  rm medical com­pression stockings should be removed over nighttime.  e main advantage of elastic material is that it can also be handled by nonexperienced sta and even by the patients t h em s e l v e s .
Short-stretch material and completely rigid devices show a high working pressure with high peaks during walk­ing that are able to occlude leg veins intermittently, thereby
9
reducing ambulatory venous hypertension.
During walking, nonyielding material will exert similar e ects as intermittent pneumatic compression, especially concerning the release of anti-in ammatory, anticoagula­tory, and vasoactive mediators from the endothelial cells.
10
 ese e ects are probably the reason for the fact that the best healing rates of venous ulcers have been described with
11
multilayer high-pressure bandages.
A considerable fall of pressure will occur when the patient lies down, so that short-stretch bandages may better be tolerated in the resting position.  e pressure loss of up to 40% in the  rst two hours is caused by an immediate reduction of the limb volume and should be taken into account by applying an inelastic bandage with a much higher strength than an elastic ban­dage, which needs some experience. Due to the pressure fall, inelastic bandages are well tolerated also during nighttime. In patients with massive edema they should be reapplied a er short periods of time in the initial phase when they get loose. Later on they may be worn for one week and lon­ger. In the presence of arterial occlusions inelastic bandages should be applied with a very low resting pressure, which should be adjusted to the systolic ankle pressure in order not to interfere with the reduced arterial in ow. During move­ment there will be a massage of the limb, which may be com­pared with intermittent pneumatic compression. Bandages
THERAPY PHASE AND
MAINTENANCE PHASE OF
COMPRESSION THERAPY
In general, we prefer multilayer short-stretch or completely nonelastic material for the therapy phase of severe stages of chronic venous insu ciency like venous ulcers, for lymph­edema, and also for acute phlebitis and deep vein thrombo-
13
When the leg ulcers are healed and when the extremity
sis. is fairly free from edema, elastic material (preferably com­pression stockings) is used in order to maintain this condi­tion (maintenance phase).
PHYSIOLOGICAL EFFECTS OF
COMPRESSION THERAPY
Some physiological e ects of compression therapy as docu­mented in several studies are summarized in Table9.3.
 e application of continuous compression is contrain­dicated in patients with advanced peripheral arterial disease or severe sensory impairment.
Several e ects of compression therapy have been dem­onstrated in the acute experiment using intermittent pneu­matic compression. It may be assumed that similar e ects will also occur during walking with inelastic bandages.
TISSUE PRESSURE ANDEDEMA
By increasing the tissue pressure, compression works against  ltration, which is the most important mechanism to
Table9.3 EFFECTS OF COMPRESSION THERAPY
STOCKINGS AND BANDAGES
PARAMETERS EFFECT
Tissue pressure Edema Venous volume Venous velocity Blood shi into central compartments Venous re uxes Venous pump Arterial  ow
Microcirculation Lymph drainage
Increase Decrease Decrease Increase Increase Decrease Improvement Increase (intermittent
compression) Improvement Improvement
1,14
MECHANISM AND EFFECTS OF COMPRESSION THERAPY • 81
prevent or to remove edema. Occupational leg swelling in
https://t.me/med1917
sitting and standing professions can be prevented by light compression stockings, which are also able to reduce mild
15
edema.
Reduction in intradermal edema can be measured with ultrasonography in patients with CVI and lipoderma­tosclerosis. Severe stages of limb swelling bene t more from inelastic compression devices exerting higher pressure.
Compression may reveal bene cial e ects also in non­phlebological causes of edema like in ammatory edema (arthritis, cellulitis), cardiac, dysproteinemic, renal edema,
2
lymphedema, and cyclic idiopathic edema.
VENOUS VOLUME AND VENOUS
BLOOD FLOW VELOCITY
Depending on the exerted pressure and the body position, external compression is able to narrow or to occlude super-
16
 cial and deep leg veins.
In the supine position an external pressure of 10–15mmHg is enough to decrease the venous diameter.  e resulting increase of blood  ow velocity as clearly
17
shown by measuring the circulation time with isotopes
is the rationale for recommending light compression stock­ings for thromboprophylaxis in bedridden patients.
Venous volume can be assessed using air-plethysmography (APG), which shows a signi cantly more pronounced reduction by inelastic than by elastic compression, even
5
when the resting pressure is thesame.
In the upright position elastic stockings will have only a minor e ect on decreasing the diameter of the leg veins.
18
However, a very small decrease of venous diameter will result in an overproportional decrease of the local blood volume
5,14
as demonstrated by several plethysmographic studies
BLOOD SHIFT INTO CENTRAL
COMPARTMENTS
Firm compression bandages applied on both lower extremi­ties may redistribute blood toward the central parts of the body.  is can lead to an increase of the preload of the heart by about 5% and should be avoided in patients with border-
19
line cardiac function.
DECREASE OF VENOUS REFLUXES
AND IMPROVEMENT OF THE
VENOUSPUMP
Using APG in patients with deep venous incompetence, it could be shown that compression with increasing interface pressure was associated with a decreasing amount of total re ux measured by venous  llingindex.
A statistically signi cant reduction of re uxes was achieved with pressures over 30mmHg for inelastic and
5
over 40mmHg for elastic material.
 e reduction of venous re uxes in patients with chronic venous insu ciency by external compression explains the improvement of the venous pumping func­tion. Plethysmographic studies have shown an increasing improvement of the venous pump with increasing stock­ing pressures, starting with an ankle pressure of around
9,20–23
20mmHg.
Higher compression pressure using sti material leads to short phases of intermittent occlusion of the deep veins with every step during muscle contraction. Such intermit­tent occlusions of deep veins on the leg can be visualized
16
by Duplex.
By encasing the veins in a rigid envelope
ambulatory venous hypertension may thereby be reduced
9
in patients with deep venous incompetence.
Similarly, a progressively increasing pressure on the thigh by using a blood pressure cu blown up to 40–80mmHg led to a pro­gressively decreasing vein diameter and to an abolishment of re ux when the femoral vein segment contained incom-
20
petent valves.
Reduction of venous re uxes and improve­ment of ambulatory venous hypertension by external cu compression could be demonstrated even in patients with­out any valves (avalvulia).  is e ect therefore cannot be explained by the common explanation of a coaptation of distended valve lea ets, but seems rather to be due to the intermittent occlusion of the incompetent vein during
21
walking.
Con icting results have been reported concerning an
improvement of ambulatory venous hypertension by com-
2,9
pression stockings. the pressure exerted by stockings is too low in order to su ­ciently compress the veins in the leg in the upright position.
 is may be explained by the fact that
In addition, the elastic material gives way with every step, whereas inelastic, short-stretch bandages with a double as high resting pressure are able to achieve intermittently short venous occlusions during muscle systole while walking. In patients with severe stages of chronic venous insu ciency a higher compression pressure is needed to improve the dis­turbed venous pumping function, whereas lower pressure is
22
su cient in simple varicose veins.
 e key mechanism of compression therapy to reduce ambulatory venous hypertension in patients with severe chronic venous insu ciency is an intermittent occlusion of the veins during walking.
In contrast, continuous obliteration of veins by external compression may be desirable a er varicose vein surgery in order to stop bleeding and a er sclerotherapy to prevent re lling ofblood.
To achieve complete venous occlusion the external pres­sure has to be higher than the intravenous pressure, depend­ing on the body position. By Duplex ultrasonography and by MRI it could be demonstrated that an occlusion of super cial leg veins can be obtained with an external pres­sure in the range of 20mmHg in the supine position, but that in the sitting and standing positions the pressure has
16,24
to be between 50 and 70 mmHg.
With compression
82 • BASIC CONSIDERATIONS
stockings such pressure ranges can be achieved only when
https://t.me/med1917
rolls or pads are applied over the vein. According to the law of Laplace this will increase the local pressure due to the
25
reduction of the local radius.
ARTERIAL FLOW AND
MICROCIRCULATION
A reduction of arterial  ow will occur when the external compression pressure exceeds the intra-arterial pressure.  is may happen in patients with arterial occlusive dis­ease with a reduced peripheral arterial pressure. In order to avoid ischemic skin lesions from external compression it is therefore essential to measure the peripheral arterial pressure by a Doppler probe before strong compression bandages or stockings are applied. It is generally accepted that a Doppler ankle-brachial index (ABI) of less than 0.5 is a contraindication for compression therapy. However, external compression does not invariably mean reduc­tion of arterial  ow. H.N. Mayrovitz reported on several experiments concerning arterial blood  ow and compres­sion and was able to demonstrate an increase of the pul­satile  ow below the knee in healthy volunteers using
26
nuclear magnetic resonance  owmetry.
An increase of arterial  ow under the bandages could also be shown in patients with mixed, arteriovenous ulcers and an ABPI of >0.6 when inelastic material was applied up to a pressure
27
of 40mmHg.
Patients with edematous legs and with an ABI between
0.5 and 0.8 may bene t from inelastic or short-stretch bandages applied with a mild resting pressure due to the edema-removing massage e ect that will occur with every ankle movement. In patients with mixed ulceration it could be demonstrated that inelastic bandages applied with a pres­sure up to 40mmHg were able to increase arterial  ow and
27
to improve the venous pumping function.
Completely inelastic bandages together with walking have a similar e ect as intermittent pneumatic compression.  e rhythmic pressure peaks of an inelastic bandage during walking can be compared with those exerted by an intermittent pneu­matic pressure pump. Several experiments with intermittent pneumatic compression have demonstrated an increase of arterial  ow in patients with arterial occlusive disease.
28,29
 e deciding mechanisms of action are the reduction of edema, an increase of the arteriovenous pressure gradient, myogenic mechanisms, and the release of vasoactive sub-
30
stances from the endothelial cells
Compression accelerates blood  ow in the enlarged cap­illary loops and reduces capillary  ltration due to enhanced tissue pressure. Blood  ow and partial oxygen tension in the skin increase and the endothelial adhesion of leukocytes is normalized. Di erent studies using electron microscopy were able to show a restoration of the structural changes in the media myocytes in stripped veins and a tighten­ing of intercellular junctions. Increasing  ow velocity
demonstrated by laser Doppler  uxmetry may reduce the likelihood of white blood cells interacting or sticking to
31
endothelium with release of various factors.
E ects on mediators involved in the local in ammatory response may explain both the immediate pain relief that occurs with good compression, and ulcer healing.
Model experiments with intermittent pneumatic com­pression were able to demonstrate that there is an increased release of  brinolytic mediators and of the endothelial relaxing factor (EDRF) nitrogen oxide from the endothelial cells depending on the amount of shear stress produced by
10,30
the compression waves.
L Y M P H D R A I N A G E
Several bene cial mechanisms of compression therapy on the swollen extremity may be explained by its e ects on the
32
lymphatic system:
•
Reduction of capillary  ltration
•
Shi of  uid into noncompressed parts of thebody
•
Increase of lymphatic reabsorption and lymphatic
transport
•
Breakdown of  brosclerotictissue
•
Downregulation of proin ammatory cytokines and
receptors for growth factors.
External compression increases the interstitial pres­sure and prevents  uid from  ltering out of the capillary network.  e amount of the lymphatic load is thereby decreased.
Compression removes more water than protein from the tissue, thereby increasing oncotic tissue pressure and reinforcing the need for sustained compression.  erefore in chronic edema, success is dependent on continued compression.
Compression together with movement enhances the contraction of the lymphangion.
It has been demonstrated that both compression ban­daging and exercise stimulate the movement of stagnat­ing lymph through the lymph collector in lymphedema patients, in which the lymphatic trunks are  lled.  is is probably one explanation for the reduction of intralym­phatic hypertension by complex decongestive therapy.
Intermittent pneumatic compression enhances prefas­cial lymph drainage. Unna boots are able to increase subfas­cial lymph transport, which is reduced in postthrombotic syndrome.
Consequent compression leads to a morphological improvement of pathological initial lymphatics in patients with lipodermatosclerosis, which can be demonstrated by indirect x-ray lymphography.
MECHANISM AND EFFECTS OF COMPRESSION THERAPY • 83
CLINICAL EFFECTS OF
https://t.me/med1917
COMPRESSION THERAPY
 e use of compression therapy in various clinical indica­tions is based mainly on experience.
Only a few randomized controlled trials (RCTs) are
available that prove the e cacy of compression treatment
33
on the level of evidence-based medicine.
Table9.4 summarizes the outcome of an international consensus meeting in which all RCTs and systematic reviews have been scored.
 ere are only three areas for which evidence-based medicine data show clear clinical bene ts of compression therapy:active venous ulceration, prevention of postthrom­botic syndrome a er deep vein thrombosis, and prevention of thromboembolic events a er surgery when combined with anticoagulatory prophylaxis.
In venous ulcers several RCTs have shown that com­pression is better than no compression and that high pres­sure is more e ective than low pressure. Con icting results are coming from studies comparing di erent compression materials, mainly due to the fact that frequently, good ban­dages have been compared with poor bandages applied by inadequately trained sta .  is underlines the need to mea­sure pressure and sti ness of the compression products in future trials.
Compression stockings a er proximal deep vein throm­bosis are able to reduce the incidence of a postthrombotic syndrome some years a er the acute event to one half. Immediate mobilization of mobile patients with deep vein
thrombosis using compression has been shown not only to reduce pain and swelling in the acute stage but also to achieve less postthrombotic changes a er someyears.
 e overview given in Table 9.4 does not mean that compression is less or not e ective in areas with recommen­dation levels B and C, but that we need more trials in order to improve the scienti c evidence for compression devices in the future.
R E F E R E N C E S
1. CEN European Prestandard . Medical compression hosiery . Brussels:
European Committee for Standardization . 2001 . 1–40 .
2. Partsch H , Rabe E , Stemmer R . Compression therapy of the extremities .
Paris : Editions Phlébologiques Francaises . 1999 .
3. Partsch H , Mosti G.Comparison of three portable instruments to
measure compression pressure , Int Angiol . 2010. 29 ( 5 ): 426–430.
4. Partsch H , Clark M , Bassez S , etal. Measurement of lower leg com-
pression in vivo:Recommendations for the performance of measure­ments of interface pressure and sti ness: A consensus statement , Dermatol Surg . 2006 . 32 : 229–238 .
5. Partsch H , Menzinger G , Mostbeck A . Inelastic leg compression is
more e ective to reduce deep venous re uxes than elastic bandages , Dermatol Surg . 1999 . 25 : 695–700 .
6. Stolk R , Wegen van der-Franken CPM , Neumann , HAM . A method
for measuring the dynamic behavior of medical compression hosiery during walking , Dermatol Surg . 2004 . 30 : 729–736 .
7. Partsch H .  e static sti ness index:Asimple method to assess the
elastic property of compression material in vivo , Dermatol Surg . 2005 . 31 : 625–630 .
8. Partsch H , Partsch B , Braun W . Interface pressure and sti ness of
ready made compression stockings: Comparison of in vivo and in vitro measurements . J Vasc Surg . 2006. 44 ( 4 ): 809–814 .
Table9.4 RCTS AND SYSTEMATIC REVIEWS ON COMPRESSION THERAPY FIRST COLUMN:INDICATIONS, FOLLOWING THE CEAP CLASSIFICATION; SECOND COLUMN:NUMBER OF RCTS IDENTIFIED; COLUMNS 37:LEVELS OF RECOMMENDATION A, B, C SEE LATER FOR BANDAGES COLUMN 3OR DIFFERENT STOCKINGS WITH THEIR PRESSURE RANGES COLUMNS47
INDICATION REF # BANDAGE STOCKING 1014 STOCKING 1521 STOCKING 2332 STOCKING 3446
C0S, C1S C1 Sclerother C2A C2S C2 Pregnancy C2 Surgery C2 Sclerother C3 C4b (LDS) C5 C6 DVT Prevention Flight DVT  erapy PTS Prevention Lymphedema
Levels of Recommendation: A:Large RCTs, meta-analysis of homogeneous results B:Only one or smallerRCTs C:Observational studies, consensus among participants of the consensus meeting
3 2 1 1 1 7 3 1
1 Multiple Multiple Multiple
2
3
3
5
C C
A
B
B
B
C
A–B
B
B
B
C
B
A-B
B B
B C
B C
B B B B
A
C
B
C
C C
B
A
C
84 • BASIC CONSIDERATIONS
9. Partsch H . Improvement of venous pumping function in chronic
https://t.me/med1917
venous insu ciency by compression depending on pressure and material , VA S A . 1984 . 13 : 58–64 .
10. Dai G , Tsukurov O , Orkin RW , Abbott WM , Kamm RD , Gertler JP . An in vitro cell culture system to study the in uence of external pneumatic compression on endothelial function , J Vasc Surg . 2000 . 32 : 977–987 .
11. O’Meara S , Cullum NA , Nelson EA. Compression for venous leg ulcers, Cochrane Database Syst Rev . 2009 . 1 : CD000265.
12. Kessler CM , Hirsch DR , Jacobs H, etal. Intermittent pneumatic compression in chronic venous insu ciency favorably a ects  bri­nolytic potential and platelet activation , Blood Coagul Fibrinolysis . 1996 . 7 : 437–446 .
13. Blättler W , Partsch H . Leg compression and ambulation is better than bed rest for the treatment of acute deep vein thrombosis , Int Angiol . 2003 . 22 : 393–400 .
14. Vin F , Benigni JP . Compression therapy:International Consensus Document Guidelines according to scienti c evidence , Int Angiol . 2004 . 23 : 317–345 .
15. Partsch H , Winiger J , Lun B . Compression stockings reduce occupa­tional swelling , J Derm Surg . 2004 . 30 : 737–743 .
16. Partsch B , Partsch H . Pressure dose for leg vein compression ther­apy?, J Vasc Surg . 2005 . 42 : 734–738 .
17. Partsch H , Kahn P . Venöse Strömungsbeschleunigung in Bein und Becken durch “Anti- rombosestrümpfe,” Klinikarzt . 1982 . 11 : 609–615 .
18 Lord RS , Hamilton D . Graduated compression stockings (20–
30mm Hg ) do not compress leg veins in the standing position , ANZ J Surg . 2004 . 74 : 581–583 .
19. Mostbeck A , Partsch H , Peschl L . Änderungen der Blutvolumenverteilung im Ganzkörper unter physikalischen und pharmakologischen Maßnahmen , VA S A . 1977 . 6 : 137–141 .
20. Partsch H , Menzinger G , Borst-Krafek B , Groiss E . Does thigh com­pression improve venous hemodynamics in chronic venous insu ­ciency?, J Vasc Surg. 2002 . 36 : 948–952 .
21. Partsch B , Mayer W , Partsch H . Improvement of ambulatory venous hypertension by narrowing of the femoral vein in congenital absence of venous valves , Phlebology . 1992 . 7 : 101–104 .
22. Stöberl C , Gabler S , Partsch H . Indikationsgerechte Bestrumpfung:Messung der venösen Pumpfunktion , 18 : 35–39 .
23. Mosti G , Partsch H . Measuring venous pumping function by strain-gauge plethysmography , Int Angiol . 2010. 29 ( 5 ): 421–425.
24 Partsch H , Mosti G , Mosti F . Narrowing of leg veins under com-
pression demonstrated by magnetic resonance imaging (MRI), Int Angiol . 2010. 29 ( 5 ): 408–410.
25 Partsch B , Partsch H . Which pressure do we need to compress
the great saphenous vein on the thigh?, Dermatol Surg . 2008. 34 ( 12 ): 1726–1728.
26. Mayrovitz HN . Compression-induced pulsatile blood  ow changes in human legs, Clin Physiol . 1998 . 18 : 117–124 .
27 Mosti G , Iabichella ML , Partsch H . Compression therapy in mixed
ulcers increases venous output and arterial perfusion , J Vasc Surg .
2012. 55 ( 1 ): 122–128.
28. Delis KT , Nicolaides AN . E ect of intermittent pneumatic com­pression of foot and calf on walking distance, hemodynamics, and quality of life in patients with arterial claudication:Aprospective randomized controlled study with 1-year follow-up , Ann Surg . 2005 . 241 ( 3 ): 431–441 .
29 Labropoulos N , Wierks C , Su oletto B . Intermittent pneumatic
compression for the treatment of lower extremity arterial dis­ease:Asystematic review , Vasc Med. 2002. 7 ( 2 ): 141–148.
30 Chen AH , Frangos SG , Kilaru S , Sumpio BE . Intermittent pneu-
matic compression devices:Physiological mechanisms of action , Eur J Vasc Endovasc Surg . 2001. 21 ( 5 ): 383–392 .
31. Abu-Own A , Shami SK , Chittenden SJ , Farrah J , Scurr JH , Smith PD . Microangiopathy of the skin and the e ect of leg compression in patients with chronic venous insu ciency , J Vasc Surg . 1994 . 19 : 1074–1083 .
32. Földi E , Jünger M , Partsch H .  e science of lymphoedema bandag- ing, EWMA Focus Document:Lymphoedema bandaging in practice . London : MEP . 2005 . 2–4 .
33. Partsch H , Flour M , Smith PC , International Compression Club. Indications for compression therapy in venous and lymphatic disease consensus based on experimental data and scienti c evidence , Int
Angiol . 2008. 27 ( 3 ): 193–219.
VA S A
. 1989 .
MECHANISM AND EFFECTS OF COMPRESSION THERAPY • 85
10.
https://t.me/med1917
CLASSIFYING VENOUS DISEASE
BoEklöf
he Swedish physician and scientist Carl von Linné published a classi cation of plants based on the num-
T
Today, classi cation of diseases is a basic instrument for uni­form diagnosis and meaningful communication about disease. In chronic venous disorders (CVD), reliance for too long has been placed on the clinical appearance of the super cial e ects of CVD, such as spider veins, varicose veins, swelling, skin changes, and ulcerations, without requiring accurate objec­tive testing of the venous system to substantiate the diagnosis.  is practice has caused errors of diagnosis and has been largely responsible for the poor correlation of results between treat­ment methods.  ere have been several classi cations in the past that have added to our understanding of CVD, but all lack the completeness and objectivity needed for scienti c accuracy.
 e most commonly used classi cation, particularly in Europe, was Widmer’s 1978 venous insu ciency:
ber of stamina and pistils in 1735 in Systema Naturae .
P R E V I O U S
CLASSIFI CATIONSOFCVD
1
classi cation of chronic
Stage I :Edema and dilated subcutaneous veins with
corona phlebectatica
Grade III :Re ux to just below theknee
Grade IV :Total re ux to theankle
Hach’s thesis was that in severe re ux of the GSV, a vicious internal circle developed because of the large venous blood volume with dilatation of the popliteal and femo­ral veins leading to deep venous incompetence if the GSV incompetence was not treated.
In 1980, one could achieve further improvement from other means a er compression therapy. Could surgery or sclerotherapy be helpful? He recommended a classi cation based on involvement of super cial, perforator, and deep veins using objective measures such as foot volumetry and ambula­tory venous pressure to discriminate between “betterable” ( bess-erbare ) and “not betterable” ( nicht besserbare ) patients.
In 1985, to the present CEAP (clinical, etiological, anatomic, patho­physiologic) classi cation, as follows.
Stages of regional circulatory-trophic disorders:
•
Compensation
3
Partsch asked whether in patients with CVD
4
Sytchev published a classi cation very similar
CLINICAL CLASSES
Stage II :Trophic lesions of the skin with hyper- or
depigmentedareas
Stage III :Healed or activeulcer
 is clinical classi cation was criticized for the nonspec­i city of Stage Iand the absence of di erentiation between trophic changes in StageII.
In 1979 vein (GSV) incompetence:
Grade I :Re ux in thegroin
Grade II :Re ux to above theknee
2
Hach suggested a grading of great saphenous
•
Decompensation (cyanosis, edema, cruralgia, or legpain)
Degrees:
•
By the end of theday
•
Bymidday
•
At the beginning of theday
Phases:
•
Functional trophic disorders (hyper-, hypo-, and
anhidrosis of theskin)
86
• Preulcer condition of tissues
https://t.me/med1917
•
Trophiculcers
Etiology:
•
Primary venous dilatation
•
Secondary (postthrombotic) occlusion and
recanalization
•
Congenital dysplasias
9
In 1993,
Miranda etal. published a clinical classi cation:
Stage I :Dilatation of GSV 7mm by duplex scanning
Stage II :Dilatation of GSV > 7mm without skin
changes
Stage III :Stage II plus skin changes
Stage IV :Stage III plus active or healedulcer
Central hemodynamics
•
Compensation
•
Decompensation
— Underloaded — Overloaded
5
 e same year,
Pierchalla and Tronnier suggested dif­ferentiation between primary and secondary (postthrom­botic) disease, and between super cial, perforator, and deep venous disease using objective measures.
6
In 1988,
Porter etal. published reporting standards for venous disease developed by an ad hoc committee for the Society for Vascular Surgery (SVS) and the North American chapter of the International Society for Cardiovascular Surgery (ISCVS).  is was similar to and based on the Widmer classi cation with the addition of etiology and anatomic distribution.  is was the stimulus for the CEAP classi cation that followedlater.
7
In 1991,
Cornu- énard etal. published a clinical clas­si cation of the severity of varicose veins by inspection and palpation and calculated the sum of maximum diameter at seven sites of theleg.
8
In 1992,
Enrici and Caldevilla published a clinical clas­si cation on the evolution of the postthrombotic syndrome:
Stage 1 :Early postthrombotic syndrome with painful
swelling of the leg with distal venous hypertension and venographically demonstrating residual obstruction of the deep veins with competent perforators
THE CREATION OF THE CEAP
CLASSIFIC AT ION
At the   h annual meeting of the American Venous Forum (AVF) in 1993, John Porter suggested using the TNM clas­si cation for cancer as a model to develop a classi cation system for venous diseases. Following a year of intense discussions a consensus conference was held at the sixth annual meeting of AVF in February 1994 on the island of Maui, Hawaii, at which an international ad hoc committee, chaired by Andrew Nicolaides, and with representatives from Australia, Europe, and the United States, developed
10
the  rst CEAP consensus document.
It contained two parts, a classi cation of CVD and a scoring system of the severity of CVD.  e classi cation was based on clinical manifestations (C), etiologic factors (E), anatomic distri­bution of disease (A), and the underlying pathophysiologic  ndings (P), thus the name CEAP.  e severity scoring system was based on three elements:the number of ana­tomic segments a ected, grading of symptoms and signs, and disability.  e CEAP consensus statement was pub­lished in 26 journals and books in nine languages, truly a universal document for CVD. It was endorsed by the Joint Councils of the SVS and the North American Chapter of the ISCVS, and its basic elements were incorporated
11
into venous reporting standards.
Today most published clinical papers on CVD use all or portions of the CEAP classi cation.
Stage 2 :Compensatory hypertrophy of the
musculovenous calf musclepump
Stage 3 :Stage 2 plus appearance of secondary varicose
veins. Venography shows recanalization with varying re ux with incompetent perforators;
Stage 4 :Advanced chronic venous insu ciency with
development of a vicious venous recirculation with lipodermatosclerosis and ulceration due to venous hypertension
Stage 5 :Phleboarthrotic syndrome with
immobilization of theankle.
Stage 6 :Secondary, postthrombotic lymphedema
REVISION OFCEAP
Diagnosis and treatment of CVD were developed rap­idly in the 1990s, and the need for an update of the clas­si cation logically followed. Now, it is important to stress that CEAP is a descriptive classi cation. Venous Severity
12
Scoring (VSS)
was developed to allow longitudinal out­comes assessment, but it became apparent that CEAP itself required updating and modi cation. In April 2002, the AVF appointed an ad hoc committee on CEAP to review the classi cation and make recommendations for change by 2004, 10years a er its introduction (see Table10.1). An International ad hoc committee was also established to assure continued universal utilization (see Table10.2).
CLASSIFYING VENOUS DISEASE • 87